Literature DB >> 12502881

Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deleted.

Masato Yamamoto1, Julia Davydova, Koichi Takayama, Ramon Alemany, David T Curiel.   

Abstract

We analyzed the transcription initiation activity of the left-end sequence (first 342 bp) of the adenovirus genome in the context of an adenovirus vector with E1 deleted in in vitro and in vivo gene transfer models. While nucleotide sequences 1 to 190 and 1 to 342 showed strong activity in three out of three lung cancer cell lines, nucleotide sequence 1 to 103 showed limited activity in H358, cells which show characteristics of type 2 alveolar cells. In vivo, the transcription initiation activities of nucleotide sequence 1 to 103 in the liver and the lung were minimal, while nucleotide sequences 1 to 190 and 1 to 342 showed strong activity comparable to that of the cytomegalovirus promoter. Further understanding of the transcription initiation activity of the left-end sequence of the adenovirus genome should lead to optimization of adenovirus vectors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502881      PMCID: PMC140768          DOI: 10.1128/jvi.77.2.1633-1637.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.

Authors:  D S Steinwaerder; A Lieber
Journal:  Gene Ther       Date:  2000-04       Impact factor: 5.250

2.  Potential limitations of transcription terminators used as transgene insulators in adenoviral vectors.

Authors:  M Buvoli; S J Langer; S Bialik; L A Leinwand
Journal:  Gene Ther       Date:  2002-02       Impact factor: 5.250

3.  Deletion analysis of GAL4 defines two transcriptional activating segments.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-03-13       Impact factor: 41.582

4.  The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis.

Authors:  P Hearing; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

5.  Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.

Authors:  M Brower; D N Carney; H K Oie; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

6.  Intrabronchial orthotopic propagation of human lung adenocarcinoma--characterizations of tumorigenicity, invasion and metastasis.

Authors:  Kentaro Mase; Tatsuo Iijima; Naoko Nakamura; Tomoyo Takeuchi; Masataka Onizuka; Toshio Mitsui; Masayuki Noguchi
Journal:  Lung Cancer       Date:  2002-06       Impact factor: 5.705

7.  The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

Authors:  P Hearing; T Shenk
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

8.  Xenobiotic-metabolizing enzyme activity in human non-small-cell derived lung cancer cell lines.

Authors:  M Falzon; J B McMahon; H M Schuller
Journal:  Biochem Pharmacol       Date:  1986-02-15       Impact factor: 5.858

Review 9.  Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer.

Authors:  A R Black; J D Black; J Azizkhan-Clifford
Journal:  J Cell Physiol       Date:  2001-08       Impact factor: 6.384

10.  Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.

Authors:  I A Hope; K Struhl
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

View more
  5 in total

1.  In vitro and in vivo analysis of expression cassettes designed for vascular gene transfer.

Authors:  S J White; E D Papadakis; C A Rogers; J L Johnson; E A L Biessen; A C Newby
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

2.  Local character of readthrough activation in adenovirus type 5 early region 1 transcription control.

Authors:  Li Shen; David J Spector
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 3.  Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.

Authors:  Dirk M Nettelbeck
Journal:  J Mol Med (Berl)       Date:  2007-12-19       Impact factor: 4.599

4.  Adenoviral vector-based strategies for cancer therapy.

Authors:  Anurag Sharma; Manish Tandon; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Drug ther       Date:  2009-05-01

5.  Oncolytic adenoviruses: A thorny path to glioma cure.

Authors:  I V Ulasov; A V Borovjagin; B A Schroeder; A Y Baryshnikov
Journal:  Genes Dis       Date:  2014-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.